Since the onset of the COVID-19 pandemic, telehealth has become a much wider practice, enabling millions to receive care at home. Genetic screening, testing, and counseling are particularly amenable to telehealth, but their future remains to be seen. On this episode of CANCER BUZZ, we look at how genetic healthcare services have adapted to virtual delivery, and what challenges face its widespread use after the pandemic is over.

Guest: Feyi Olopade Ayodele, MBA, Chief Executive Officer, CancerIQ, Inc.

Related Content:

• ACCC 47th Annual Meeting & Cancer Center Business Summit
• ACCC Telehealth Page
• Episode 26: Telehealth after COVID-19
• Bringing Genetic Testing Closer to Home
• 7 Ways COVID-19 Is Transforming Telehealth
• Taskforce on Telehealth Policy, National Committee for Quality Assurance

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.